1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Chidamide Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 5 mg
  • 1.3.3 20 mg
• 1.4 Market Analysis by Combination Therapy
  • 1.4.1 Overview: Global Chidamide Tablets Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
  • 1.4.2 Combination With Aromatase Inhibitors
  • 1.4.3 Combination With CD20 Monoclonal Antibodies
• 1.5 Market Analysis by Sales Channels
  • 1.5.1 Overview: Global Chidamide Tablets Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
  • 1.5.2 Hospital
  • 1.5.3 Retail
  • 1.5.4 Online
• 1.6 Market Analysis by Application
  • 1.6.1 Overview: Global Chidamide Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.6.2 Peripheral T-Cell Lymphoma
  • 1.6.3 Breast Cancer
  • 1.6.4 Diffuse Large B-Cell Lymphoma
  • 1.6.5 Others
• 1.7 Global Chidamide Tablets Market Size & Forecast
  • 1.7.1 Global Chidamide Tablets Consumption Value (2021 & 2025 & 2032)
  • 1.7.2 Global Chidamide Tablets Sales Quantity (2021-2032)
  • 1.7.3 Global Chidamide Tablets Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Shenzhen Chipscreen Biosciences
  • 2.1.1 Shenzhen Chipscreen Biosciences Details
  • 2.1.2 Shenzhen Chipscreen Biosciences Major Business
  • 2.1.3 Shenzhen Chipscreen Biosciences Chidamide Tablets Product and Services
  • 2.1.4 Shenzhen Chipscreen Biosciences Chidamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Shenzhen Chipscreen Biosciences Recent Developments/Updates

3 Competitive Environment: Chidamide Tablets by Manufacturer

• 3.1 Global Chidamide Tablets Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Chidamide Tablets Revenue by Manufacturer (2021-2026)
• 3.3 Global Chidamide Tablets Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Chidamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Chidamide Tablets Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Chidamide Tablets Manufacturer Market Share in 2025
• 3.5 Chidamide Tablets Market: Overall Company Footprint Analysis
  • 3.5.1 Chidamide Tablets Market: Region Footprint
  • 3.5.2 Chidamide Tablets Market: Company Product Type Footprint
  • 3.5.3 Chidamide Tablets Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Chidamide Tablets Market Size by Region
  • 4.1.1 Global Chidamide Tablets Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Chidamide Tablets Consumption Value by Region (2021-2032)
  • 4.1.3 Global Chidamide Tablets Average Price by Region (2021-2032)
• 4.2 North America Chidamide Tablets Consumption Value (2021-2032)
• 4.3 Europe Chidamide Tablets Consumption Value (2021-2032)
• 4.4 Asia-Pacific Chidamide Tablets Consumption Value (2021-2032)
• 4.5 South America Chidamide Tablets Consumption Value (2021-2032)
• 4.6 Middle East & Africa Chidamide Tablets Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Chidamide Tablets Sales Quantity by Type (2021-2032)
• 5.2 Global Chidamide Tablets Consumption Value by Type (2021-2032)
• 5.3 Global Chidamide Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Chidamide Tablets Sales Quantity by Application (2021-2032)
• 6.2 Global Chidamide Tablets Consumption Value by Application (2021-2032)
• 6.3 Global Chidamide Tablets Average Price by Application (2021-2032)

7 North America

• 7.1 North America Chidamide Tablets Sales Quantity by Type (2021-2032)
• 7.2 North America Chidamide Tablets Sales Quantity by Application (2021-2032)
• 7.3 North America Chidamide Tablets Market Size by Country
  • 7.3.1 North America Chidamide Tablets Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Chidamide Tablets Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Chidamide Tablets Sales Quantity by Type (2021-2032)
• 8.2 Europe Chidamide Tablets Sales Quantity by Application (2021-2032)
• 8.3 Europe Chidamide Tablets Market Size by Country
  • 8.3.1 Europe Chidamide Tablets Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Chidamide Tablets Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Chidamide Tablets Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Chidamide Tablets Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Chidamide Tablets Market Size by Region
  • 9.3.1 Asia-Pacific Chidamide Tablets Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Chidamide Tablets Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Chidamide Tablets Sales Quantity by Type (2021-2032)
• 10.2 South America Chidamide Tablets Sales Quantity by Application (2021-2032)
• 10.3 South America Chidamide Tablets Market Size by Country
  • 10.3.1 South America Chidamide Tablets Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Chidamide Tablets Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Chidamide Tablets Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Chidamide Tablets Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Chidamide Tablets Market Size by Country
  • 11.3.1 Middle East & Africa Chidamide Tablets Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Chidamide Tablets Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Chidamide Tablets Market Drivers
• 12.2 Chidamide Tablets Market Restraints
• 12.3 Chidamide Tablets Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Chidamide Tablets and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Chidamide Tablets
• 13.3 Chidamide Tablets Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Chidamide Tablets Typical Distributors
• 14.3 Chidamide Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Chidamide Tablets market size was valued at US$ 154 million in 2025 and is forecast to a readjusted size of US$ 400 million by 2032 with a CAGR of 11.7% during review period.
Chidamide is an oral subtype-selective histone deacetylase (HDAC) inhibitor independently developed in China, belonging to a novel class of epigenetic regulatory antitumor agents. It inhibits specific HDAC subtypes, regulates chromatin remodeling and gene expression, induces cell cycle arrest, apoptosis and differentiation of tumor cells, and activates the body’s antitumor immunity. It is mainly indicated for relapsed or refractory peripheral T-cell lymphoma and is continuously expanding applications in solid tumors and combination immunotherapy, representing the first original Chinese antitumor drug granted orphan drug designation by the U.S. FDA and achieving international industrialization.In 2025, global Chidamide production reached approximately 38 million bottles
Chidamide occupies a distinct niche in the global oncology market as a first-in-class, oral, subtype-selective HDAC inhibitor, representing a landmark for China’s innovative pharmaceutical industry. Its market trajectory is shaped by strong clinical positioning in rare hematologic malignancies, strategic expansion into broader cancer indications, and progressive international adoption. Driven by the unmet need for targeted therapies in lymphoma and the growing integration of epigenetic modulators into standard treatment regimens, the market demonstrates steady expansion, supported by favorable regulatory pathways and increasing clinical acceptance. Competitive dynamics remain focused on differentiation via mechanism of action and safety profile, while long-term growth hinges on successful penetration of new therapeutic areas and sustained geographic expansion beyond its core market
This report is a detailed and comprehensive analysis for global Chidamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chidamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Chidamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Chidamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Chidamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chidamide Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chidamide Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shenzhen Chipscreen Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Chidamide Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
5 mg
20 mg
Market segment by Combination Therapy
Combination With Aromatase Inhibitors
Combination With CD20 Monoclonal Antibodies
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Application
Peripheral T-Cell Lymphoma
Breast Cancer
Diffuse Large B-Cell Lymphoma
Others
Major players covered
Shenzhen Chipscreen Biosciences
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chidamide Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chidamide Tablets, with price, sales quantity, revenue, and global market share of Chidamide Tablets from 2021 to 2026.
Chapter 3, the Chidamide Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chidamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Chidamide Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chidamide Tablets.
Chapter 14 and 15, to describe Chidamide Tablets sales channel, distributors, customers, research findings and conclusion.